Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that based on recommendation of Nomination and Remuneration Committee ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has appointed Ms. Khushbu Kachhawa (DIN: 10872432) as an Additional (Non-Executive & Independent) Women Director effective February 14, 2026, based on the recommendation of the Nomination & Remuneration Committee. She holds a B.Com. and CS Executive qualification, with about 5 years of experience in business affairs and corporate secretarial matters. The appointment is subject to shareholder approval. She is not related to the promoter or promoter group, holds no securities in the company, and is not debarred from holding a director's office by any SEBI order.
This is a routine board-level appointment to strengthen independent oversight and likely fulfill gender diversity requirements under SEBI listing rules. It is unlikely to have any material impact on the stock price or shareholder value.